BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37717420)

  • 1. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
    Yilmaz EC; Harmon SA; Belue MJ; Merriman KM; Phelps TE; Lin Y; Garcia C; Hazen L; Patel KR; Merino MJ; Wood BJ; Choyke PL; Pinto PA; Citrin DE; Turkbey B
    Eur J Radiol; 2023 Nov; 168():111095. PubMed ID: 37717420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Lin Y; Yilmaz EC; Belue MJ; Harmon SA; Tetreault J; Phelps TE; Merriman KM; Hazen L; Garcia C; Yang D; Xu Z; Lay NS; Toubaji A; Merino MJ; Xu D; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
    Radiology; 2024 May; 311(2):e230750. PubMed ID: 38713024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.
    Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Sanford TH; Kesani D; Lay NS; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Acad Radiol; 2022 Aug; 29(8):1159-1168. PubMed ID: 34598869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning-based artificial intelligence for prostate cancer detection at biparametric MRI.
    Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Kesani D; Lay N; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Abdom Radiol (NY); 2022 Apr; 47(4):1425-1434. PubMed ID: 35099572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
    Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
    J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
    Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
    Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers.
    Cipollari S; Pecoraro M; Forookhi A; Laschena L; Bicchetti M; Messina E; Lucciola S; Catalano C; Panebianco V
    Radiol Med; 2022 Nov; 127(11):1245-1253. PubMed ID: 36114928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Jakobsen H; Thomsen HS
    Eur Urol Oncol; 2019 May; 2(3):311-319. PubMed ID: 31200846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
    Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AI-assisted biparametric MRI surveillance of prostate cancer: feasibility study.
    Roest C; Kwee TC; Saha A; Fütterer JJ; Yakar D; Huisman H
    Eur Radiol; 2023 Jan; 33(1):89-96. PubMed ID: 35960339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
    [No Abstract]   [Full Text] [Related]  

  • 16. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
    Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
    Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies.
    Boesen L; Thomsen FB; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thomsen HS; Jakobsen H
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):609-616. PubMed ID: 30988407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy.
    Tsui JMG; Kehayias CE; Leeman JE; Nguyen PL; Peng L; Yang DD; Moningi S; Martin N; Orio PF; D'Amico AV; Bredfeldt JS; Lee LK; Guthier CV; King MT
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):74-84. PubMed ID: 37517600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Raince J; Park SJ; Raman SS; Nickols NG; King CR; Kishan AU; Steinberg ML; Kamrava M
    Brachytherapy; 2017; 16(6):1106-1112. PubMed ID: 28807747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.